Kane Biotech Inc. (TSX-V:KNE) (the 'Company”, 'Kane” or 'Kane Biotech”) announces today its fourth quarter and full year 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results